Renal transplantation in patients with Alport syndrome

Pediatric Transplantation

Volumn 10, Issue 6, 2006, Pages 651-657

  Kashtan, Clifford E ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Alport syndrome; Anti GBM nephritis; Renal transplantation; Type IV collagen

Indexed keywords

ANTIBODY; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE;

ALLOGENEIC STEM CELL TRANSPLANTATION; ALPORT SYNDROME; DISEASE PREDISPOSITION; GENE MUTATION; GENETIC ANALYSIS; GENETICS; GLOMERULUS BASEMENT MEMBRANE; GOODPASTURE SYNDROME; HEMATURIA; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY TRANSPLANTATION; MOLECULAR GENETICS; NEPHRITIS; ORGAN DONOR; PATIENT SELECTION; PLASMAPHERESIS; REVIEW;

CHILD; DECISION MAKING; HUMANS; KIDNEY TRANSPLANTATION; NEPHRITIS, HEREDITARY; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; TISSUE DONORS;

EID: 33746922312     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2006.00528.x     Document Type: Review

References (55)

1. JAIS JP, KNEBELMANN B, GIATRAS I, et al. X-linked Alport syndrome: natural history in 195 families and genotype-phenotype correlations in males. J Am Soc Nephrol 2000: 11: 649-657.
2. KASHTAN CE, MCENERY PT, TEJANI A, STABLEIN DM. Renal allograft survival according to primary diagnosis: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 1995: 9: 679-684.
3. VAN DER LOOP FTL, MONNENS LAH, SCHRODER CH, et al. Identification of COL4A5 defects in Alport syndrome by immunochemistry of skin. Kidney Int 1999: 55: 1217-1224.
4. MAZZUCCO G, BARSOTTI P, MUDA AO, et al. Ultrastructural and immunohistochemical findings in Alport's syndrome: a study of 108 patients from 97 Italian families with particular emphasis on COL4A5 gene mutation correlations. J Am Soc Nephrol 1998: 9: 1023-1031.
5. KASHTAN CE. Familial hematuria due to type IV collagen mutations: Alport syndrome and thin basement membrane nephropathy. Curr Opin Pediatr 2004: 16: 177-181.
6. JAIS JP, KNEBELMANN B, GIATRAS I, et al. X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a "European Community Alport Syndrome Concerted Action" study. J Am Soc Nephrol 2003: 14: 2603-2610.
7. GRUNFELD J-P, NOEL LH, HAFEZ S, DROZ D. Renal prognosis in women with hereditary nephritis. Clin Nephrol 1985: 23: 267-271.
8. BOYE E, MOLLET G, FORESTIER L, et al. Determination of the genomic structure of the COL4A4 gene and of novel mutations causing autosomal recessive Alport syndrome. Am J Hum Genet 1998: 63: 1329-1340.
9. HEIDET L, ARRONDEL C, FORESTIER L, et al. Structure of the human type IV collagen gene COL4A3 and mutations in autosomal Alport syndrome. J Am Soc Nephrol 2001: 12: 97-106.
10. LONGO I, PORCEDDA P, MARI F, et al. COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome. Kidney Int 2002: 61: 1947-1956.
11. BUZZA M, DAGHER H, WANG YY, et al. Mutations in the COL4A4 gene in thin basement membrane disease. Kidney Int 2003: 63: 447-453.
12. RANA K, WANG YY, POWELL H, et al. Persistent familial hematuria in children and the locus for thin basement membrane nephropathy. Pediatr Nephrol 2005: 20: 1729-1737.
13. NIEUWHOF CM, DE HEER F, DE LEEUW P, VAN BREDA VRIESMAN PJ. Thin GBM nephropathy: premature glomerular obsolescence is associated with hypertension and late onset renal failure. Kidney Int 1997: 51: 1596-1601.
14. COSIO FG, FALKENHAIN ME, SEDMAK DD. Association of thin glomerular basement membrane with other glomerulopathies. Kidney Int 1994: 46: 471-474.
15. VAN DER LOOP FTL, HEIDET L, TIMMER EDJ, et al. Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation. Kidney Int 2000: 58: 1870-1875.
16. CICCARESE M, CASU D, WONG FK, et al. Identification of a new mutation in the α4(IV) collagen gene in a family with autosomal dominant Alport syndrome and hypercholesterolaemia. Nephrol Dial Transplant 2001: 16: 2008-2012.
17. POCHET JM, BOBRIE G, LANDAIS P, GOLDFARB B, GRUNFELD JP. Renal prognosis in Alport's and related syndromes: influence of the mode of inheritance. Nephrol Dial Transplant 1989: 4: 1016-1021.
18. KASHTAN CE. Collagen IV-related nephropathies (Alport Syndrome and Thin Basement Membrane Nephropathy. In: GeneReviews at GeneTests: Medical Genetics Information Resource [database online]. Seattle: University of Washington, 1997-2005 (http://www.genetests.org).
19. KHANDELWAL M, MCCORMICK BB, LAJOIE G, SWEET J, COLE E, CATTRAN DC. Recurrence of anti-GBM disease 8 years after renal transplantation. Nephrol Dial Transplant 2004: 19: 491-494.
20. DIAZ JI, VALENZUELA R, GEPHARDT G, NOVICK A, TUBBS RR. Anti-glomerular and anti-tubular basement membrane nephritis in a renal allograft recipient with Alport's syndrome. Arch Pathol Lab Med 1994: 118: 728-731.
21. FLEMING SJ, SAVAGE COS, MCWILLIAM LJ, et al. Anti-glomerular basement membrane antibody-mediated nephritis complicating transplantation in a patient with Alport's syndrome. Transplantation 1988: 46: 857-859.
22. GOLDMAN M, DEPIERREUX M, DE PAUW L, et al. Failure of two subsequent renal grafts by anti-GBM glomerulonephritis in Alport's syndrome: case report and review of the literature. Transpl Int 1990: 3: 82-85.
23. KASHTAN C, FISH AJ, KLEPPEL M, YOSHIOKA K, MICHAEL AF. Nephritogenic antigen determinants in epidermal and renal basement membranes of kindreds with Alport-type familial nephritis. J Clin Invest 1986: 78: 1035-1044.
24. MCCOY RC, JOHNSON HK, STONE WJ, WILSON CB. Absence of nephritogenic GBM antigen(s) in some patients with hereditary nephritis. Kidney Int 1982: 21: 642-652.
25. MILLINER DS, PIEREDES AN, HOLLEY KE. Renal transplantation in Alport's syndrome: anti-glomerular basement membrane glomerulonephritis in the allograft. Mayo Clin Proc 1982: 57: 35-43.
26. OLIVER TB, GOULDESBROUGH DR, SWAINSON CP. Acute crescentic glomerulonephritis associated with antiglomerular basement membrane antibody in Alport's syndrome after second transplantation. Nephrol Dial Transplant 1991: 6: 893-895.
27. RASSOUL Z, AL-KHADER AA, AL-SULAIMAN M, DHAR JM, COODE P. Recurrent allograft antiglomerular basement membrane glomerulonephritis in a patient with Alport's syndrome. Am J Nephrol 1990: 10: 73-76.
28. TERUEL JL, LIANO F, MANIPASO F, et al. Allograft anti-glomerular basement membrane glomerulonephritis in a patient with Alport's syndrome. Nephron 1987: 46: 43-44.
29. VAN DE HEUVEL LPWJ, SCHRODER CH, SAVAGE COS, et al. The development of anti-glomerular basement membrane nephritis in two children with Alport's syndrome after renal transplantation: characterization of the antibody target. Pediatr Nephrol 1989: 3: 406-413.
30. BERARDINELLI L, POZZOLI E, RAITERI M, et al. Renal transplantation in Alport's syndrome: personal experience in twelve patients. Contrib Nephrol 1990: 80: 131-134.
31. GOBEL J, OLBRICHT CJ, OFFNER G, et al. Kidney transplantation in Alport's syndrome: long-term outcome and allograft anti-GBM nephritis. Clin Nephrol 1992: 38: 299-304.
32. HAYES DK, MAJESKI JA, ALEXANDER JW, et al. Renal transplantation in Alport's syndrome. Am Surg 1985: 51: 414-417.
33. NOEL LH, GUBLER MC, BOBRIE G, SAVAGE COS, LOCKWOOD CM, GRUNFELD JP. Inherited defects of renal basement membranes. Adv Nephrol 1989: 18: 77-94.
34. PETEN E, PIRSON Y, COSYNS J-P, et al. Outcome of thirty patients with Alport's syndrome after renal transplantation. Transplantation 1991: 52: 823-826.
35. OLSON DL, ANAND SK, LANDING BH, HEUSER E, GRUSHKIN CM, LIEBERMAN E. Diagnosis of hereditary nephritis by failure of glomeruli to bind anti-glomerular basement membrane antibodies. J Pediatr 1980: 96: 697-699.
36. SAUS J, WIESLANDER J, LANGEVELD JPM, QUINONES S, HUDSON BG. Identification of the Goodpasture antigen as the α3(IV) chain of collagen IV. J Biol Chem 1988: 263: 13374-13380.
37. BRAINWOOD D, KASHTAN C, GUBLER MC, TURNER AN. Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation. Kidney Int 1998: 53: 762-766.
38. DEHAN P, VAN DEN HEUVEL LPWJ, SMEETS HJM, TRYGGVASON K, FOIDART J-M. Identification of post-transplant anti-α5(IV) collagen alloantibodies in X-linked Alport syndrome. Nephrol Dial Transplant 1996: 11: 1983-1988.
39. KALLURI R, WEBER M, NETZER K-O, SUN MJ, NEILSON EG, HUDSON BG. COL4A5 gene deletion and production of posttransplant anti-α3(IV) collagen alloantibodies in Alport syndrome. Kidney Int 1994: 45: 721-726.
40. DING J, STITZEL J, BERRY P, HAWKINS E, KASHTAN C. Autosomal recessive Alport syndrome: mutation in the COL4A3 gene in a woman with Alport syndrome and posttransplant antiglomerular basement membrane nephritis. J Am Soc Nephrol 1995: 5: 1714-1717.
41. KALLURI R, VAN DEN HEUVEL LP, SMEETS HJM, et al. A COL4A3 gene mutation and post-transplant anti-α3(IV) collagen alloantibodies in Alport syndrome. Kidney Int 1995: 47: 1199-1204.
42. WANG XP, FOGO AB, COLON S, et al. Distinct epitopes for anti-Glomerular basement membrane Alport alloantibodies and Goodpasture autoantibodies within the noncollagenous domain of α3(IV) collagen: a Janus-faced antigen. J Am Soc Nephrol 2005: 16: 3563-3571.
43. MELEG-SMITH S, MAGLIATO S, CHELES M, GAROLA RE, KASHTAN CE. X-linked Alport syndrome in females. Hum Pathol 1998: 29: 404-408.
44. GUBLER MC, KNEBELMANN B, BEZIAU A, et al. Autosomal recessive Alport syndrome: immunohistochemical study of type IV collagen chain distribution. Kidney Int 1995: 47: 1142-1147.
45. KASHTAN CE, KLEPPEL MM, GUBLER MC. Immunohistologic findings in Alport syndrome. Contrib Nephrol 1996: 117: 142-153.
46. NAKANISHI K, YOSHIKAWA N, IIJIMA K, et al. Immunohistochemical study of α1-5 chains of type IV collagen in hereditary nephritis. Kidney Int 1994: 46: 1413-1421.
47. KASHTAN CE, ATKIN CL, GREGORY MC, MICHAEL AF. Identification of variant Alport phenotypes using an Alport-specific antibody probe. Kidney Int 1989: 36: 669-674.
48. NAITO I, KAWAI S, NOMURA S, SADO Y, OSAWA G. Relationship between COL4A5 gene mutation and distribution of type IV collagen in male X-linked Alport syndrome. Kidney Int 1996: 50: 304-311.
49. DING J, ZHOU J, TRYGGVASON K, KASHTAN CE. COL4A5 deletions in three patients with Alport syndrome and posttransplant antiglomerular basement membrane nephritis. J Am Soc Nephrol 1994: 5: 161-168.
50. LEMMINK HH, SCHRÖDER CH, MONNENS LAH, SMEETS HJM. The clinical spectrum of type IV collagen mutations. Hum Mutat 1997: 9: 477-499.
51. ANTIGNAC C, KNEBELMANN B, DROUOT L et al. Deletions in the COL4A5 collagen gene in X-linked Alport syndrome: characterization of the pathological transcripts in non-renal cells and correlation with disease expression. J Clin Invest 1994: 93: 1195-1207.
52. KASHTAN C, BUTKOWSKI R, KLEPPEL M, FIRST M, MICHAEL A. Posttransplant anti-glomerular basement membrane nephritis in related Alport males with Alport syndrome. J Lab Clin Med 1990: 116: 508-515.
53. KALLURI R, TORRE A, SHIELD CF, et al. Identification of α3, α4, and α5 chains of type IV collagen as alloantigens for Alport posttransplant anti-glomerular basement membrane antibodies. Transplantation 2000: 69: 679-683.
54. BROWNE G, BROWN PA, TOMSON CR, et al. Retransplantation in Alport post-transplant anti-GBM disease. Kidney Int 2004: 65: 675-681.
55. QUERIN S, NOEL LH, GRUNFELD JP, et al. Linear glomerular IgG fixation in renal allografts: incidence and significance in Alport syndrome. Clin Nephrol 1986: 25: 134-140.